Biobanking Service Market Report 2025 (Global Edition)

Global Biobanking Service Market Report 2024 Market Size Split by Biobank Type (Tissue Biobanks, Virtual Biobanks, Population-Based Biobanks, Blood Banks), by Sample Typ (Blood Products, Human Tissues...

Biobanking Service Market Report Description

We have various report editions of Biobanking Service Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Biobanking Service Market

The biobanking service market is dominated by life science giants like Thermo Fisher and Merck, offering comprehensive storage and management solutions. Niche players like Takara Bio and WuXi AppTec focus on specific areas like biorepositories and personalized medicine. Contract research organizations like Charles River provide integrated biobanking alongside drug development services. Expect rising competition from emerging players in Asia.

May 2022: BC Platforms (BCP) has obtained a multi-year contract, succeeding in a competitive bidding process, to collaborate with three Finnish Hospital District-owned Biobanks (Clinical Biobanks) with the aim of enhancing accessibility to and automating the management of phenotypic, genomic, and clinical data. This initiative supports Finland's aspiration to emerge as a frontrunner in Real-World Data (RWD) studies, contributing to the international advancement of innovative treatments and bolstering the robustness of healthcare systems. (Source: https://www.bcplatforms.com/news/bc-platforms-announces-partnerships-with-three-finnish-biobanks-to-advance-novel-diagnostics-and-treatments)

Top Companies Market Share in Biobanking Service Industry: (In no particular order of Rank)

• Thermo Fisher Scientific (United States)
• Merck KGaA (Germany)
• Laboratory Corporation of America Holdings (LabCorp) (United States)
• QIAGEN N.V. (Netherlands)
• Takara Bio Inc. (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• WuXi AppTec Co.
• Ltd. (China)
• Charles River Laboratories International Inc. (United States)
• Eurofins Scientific SE (Luxembourg)
• Avantor
• Inc. (United States)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Biobanking Service Market

Which Region Dominates the Biobanking Service Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the area's robust funding for research and development in healthcare, advanced infrastructure for biobanks, strong regulatory frameworks supporting biobanking activities, and a high prevalence of chronic diseases driving demand for biological samples. Additionally, the presence of key biopharmaceutical companies and academic research institutions conducting extensive clinical studies further bolsters North America's dominance in this sector.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is experiencing the fastest compound annual growth rate (CAGR) in the Biobanking Service Market primarily due to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and expanding biotechnology and pharmaceutical industries. Government initiatives promoting research and development, coupled with growing collaborations between academic institutions and biobanks, further stimulate market growth. Additionally, a large population base offers abundant genetic diversity, making the region attractive for biobanking activities aimed at personalized medicine and advancing biomedical research.

The current report Scope analyzes Biobanking Service Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Biobanking Service

According to Cognitive Market Research, the global Biobanking Service market size was estimated at USD 3,152.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1260.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031

• According to Cognitive Market Research, the US had a major share in the Biobanking Service market with a market size of USD 2825.00 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The demand is amplified by the nation's advanced biotechnology infrastructure, which boosts demand for modern storage solutions.
• The Canada Biobanking Service market had a market share of USD 429.66 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada's robust consumer demand and a diverse range of applications to increased usage of Biobanking Service.
• The Mexico Biobanking Service market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 325.82 million in 2024.

Europe Biobanking Service

According to Cognitive Market Research, the global Biobanking Service market size was estimated at USD 3,152.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 945.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031.

• The United Kingdom Biobanking Service market had a market share of USD 451.14 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, Biobanking Service sales witness an upswing due to increasing initiatives in personalized medicine.
• The France Biobanking Service market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 247.05 million in 2024.
• According to Cognitive Market Research, the Germany Biobanking Service market size was valued at USD 531.70 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, Biobanking Service sales surged due to supportive regulatory environments.
• The Italy Biobanking Service market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 230.94 million in 2024.
• The Russia Biobanking Service market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 416.23 million in 2024.
• The Spain Biobanking Service market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 220.20 million in 2024
• The Luxembourg Biobanking Service market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 83.25 million in 2024.
• The Portugal Biobanking Service market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 56.39 million in 2024.
• The Greece Biobanking Service market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 32.22 million in 2024.
• Rest of Europe's Biobanking Service market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 416.23 million in 2024.

Asia Pacific Biobanking Service

According to Cognitive Market Research, the global Biobanking Service market size was estimated at USD 3,152.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 725.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Biobanking Service market size was valued at USD 926.45 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Biobanking Service sales surge in China due to rising investments in healthcare infrastructure.
• The Japan Biobanking Service market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 284.11 million in 2024.
• The India Biobanking Service market had a market share of USD 247.05 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period due to rising investments in healthcare infrastructure and increasing prevalence of chronic diseases.
• The South Korea Biobanking Service market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 205.88 million in 2024.
• The Australia Biobanking Service market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 107.06 million in 2024.
• The South East Asia Biobanking Service market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 142.06 million in 2024.
• The Rest of Asia Pacific Biobanking Service market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 146.17 million in 2024.

South America Biobanking Service

According to Cognitive Market Research, the global Biobanking Service market size was estimated at USD 3,152.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 157.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Biobanking Service market size was valued at USD 191.56 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Biobanking Service sales flourish in Brazil due to rising investments in research and development.
• Argentina Biobanking Service market had a market share of USD 75.19 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. Argentina's technological advancements augment the demand to rising investments in research and development.
• Colombia Biobanking Service market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 39.83 million in 2024.
• Peru Biobanking Service market is projected to witness growth at a CAGR of 7.6% during the forecast period with a market size of USD 36.70 million in 2024.
• Chile Biobanking Service market is projected to witness growth at a CAGR of 7.8% during the forecast period with a market size of USD 32.22 million in 2024.
• The Rest of Latin America Biobanking Service market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 72.06 million in 2024.

Middle East and Africa Biobanking Service

According to Cognitive Market Research, the global Biobanking Service market size was estimated at USD 3,152.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 63.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• The GCC Countries Biobanking Service market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 76.62 million in 2024. Biobanking Service sales flourish due to increasing healthcare investments.
• The Egypt Biobanking Service market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 26.29 million in 2024.
• The South Africa Biobanking Service market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 28.29 million in 2024. Biobanking Service sales flourish in South Africa due to advancements in biotechnology.
• The Turkey Biobanking Service market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 15.40 million in 2024.
• The Nigeria Biobanking Service market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 18.80 million in 2024.
• The Rest of MEA Biobanking Service market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 21.12 million in 2024.

Biobanking Service Market Analysis

Biobanking Service Market Biobank Type Segment Analysis

According to Cognitive Market Research, Tissue Biobanks stands out as the dominating category. Tissue Biobanks have secured the largest market share in the Biobanking Service Market due to their crucial role in storing and managing human tissue samples for research and clinical applications. These biobanks facilitate studies on diseases, drug development, and personalized medicine by providing access to well-characterized tissue specimens. The increasing demand for biomarker discovery, genetic research, and regenerative medicine drives their prominence. Moreover, advancements in preservation techniques and stringent regulatory compliance further enhance the appeal and reliability of tissue biobanks.

Virtual Biobanks are experiencing the highest compound annual growth rate (CAGR) in the Biobanking Service Market due to their innovative approach in managing and sharing data rather than physical samples. This type of biobank leverages digital platforms to collect, store, and analyze vast amounts of clinical, genomic, and phenotypic data from diverse populations. Virtual biobanks offer cost-efficiency, scalability, and facilitate international collaborations in research. The increasing focus on data-driven healthcare solutions and personalized medicine is driving the rapid expansion of virtual biobanks globally.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Biobanking Service Industry. Request a Free Sample PDF!

Biobanking Service Market Sample Type Segment Analysis

According to Cognitive Market Research, the dominating Sample Type is Blood Products. Blood Products have captured the largest market share in the Biobanking Service Market due to their critical role in medical research and clinical applications. These samples are vital for studying diseases, genetic variations, and therapeutic developments. Blood products provide a readily accessible source of biomarkers and genetic material, facilitating a wide range of research studies from epidemiology to personalized medicine. Moreover, their relative ease of collection and storage, along with standardized processing protocols, contribute to their widespread adoption and dominance in the biobanking sector.

Human Tissues are experiencing the highest compound annual growth rate (CAGR) in the Biobanking Service Market due to their indispensable role in biomedical research, particularly in understanding complex diseases and developing personalized treatments. Human tissue samples provide crucial insights into genetic, molecular, and cellular mechanisms underlying diseases, offering valuable biomarkers for drug discovery and clinical trials. Advances in tissue preservation techniques and increasing collaborations between biobanks and research institutions globally further propel the growth of human tissue biobanks, driving their prominence in the market.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Biobanking Service Service Type Segment Analysis

Service Type Analysis

According to Cognitive Market Research, the dominating Service Type is Storage. Storage services have captured the largest market share in the Biobanking Service Market primarily due to the critical role they play in securely preserving biological samples for long-term storage. Biobanks offering storage services ensure the integrity, traceability, and accessibility of samples, which is crucial for ongoing research, clinical trials, and personalized medicine initiatives. Moreover, stringent regulatory requirements for sample storage and increasing demand for centralized biorepositories further drive the adoption of professional storage services among biopharmaceutical companies, academic research institutions, and healthcare organizations globally.

Processing services are experiencing the highest compound annual growth rate (CAGR) in the Biobanking Service Market due to their pivotal role in ensuring high-quality biological samples for research and clinical applications. These services involve complex procedures such as sample preparation, characterization, and quality control, which are essential for maintaining sample integrity and maximizing research outcomes. The increasing demand for standardized processing protocols, advanced technologies in sample handling, and the growing focus on biomarker discovery and personalized medicine are key drivers fueling the rapid expansion of processing services within the biobanking sector.

• Storage
• Processing
• Transport
• Supply

Biobanking Service Ownership Segment Analysis

Ownership Segment Analysis

According to Cognitive Market Research, the dominating Ownership is Academic & Research Institutes. Academic and research institutes have captured the largest market share in the Biobanking Service Market due to their extensive infrastructure, expertise in biomedical research, and collaborative networks. These institutes play a pivotal role in biobanking by conducting a wide range of studies, from basic research to clinical trials, utilizing diverse biological samples. Their ownership of biobanks ensures access to well-characterized samples and fosters innovation in medical research and drug development. Moreover, strong funding support and academic partnerships further enhance their dominance in the biobanking service market.

Pharmaceutical and biotechnology industries are experiencing the highest compound annual growth rate (CAGR) in the Biobanking Service Market due to their increasing reliance on biological samples for drug discovery, development, and personalized medicine. These industries leverage biobanks to access well-characterized specimens that aid in biomarker identification, preclinical and clinical research, and regulatory submissions. Additionally, advancements in biotechnology, personalized healthcare initiatives, and strategic collaborations with academic institutions are driving the rapid expansion of biobanking services under pharmaceutical and biotechnology ownership.

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Industries
• Hospitals
• Public Funded Biobanks
• Privately Funded Biobanks

Biobanking Service Application Segment Analysis

Application Segment Analysis

According to Cognitive Market Research, the dominating Application is Regenerative Medicine. Regenerative medicine applications have captured the largest market share in the Biobanking Service Market due to their transformative potential in treating a wide range of diseases and conditions. Biobanks play a crucial role by providing high-quality biological samples for stem cell research, tissue engineering, and cell therapy development. These applications demand well-characterized and preserved samples to advance therapies aimed at regenerating damaged tissues and organs. The growing investments in regenerative medicine and increasing clinical trials further bolster the prominence of biobanks supporting this field.

Clinical research applications are experiencing the highest compound annual growth rate (CAGR) in the Biobanking Service Market due to the expanding scope of biomedical research and drug development initiatives globally. Biobanks are essential for collecting and storing diverse biological samples linked to clinical data, crucial for conducting epidemiological studies, biomarker discovery, and clinical trials. The increasing emphasis on personalized medicine, regulatory requirements for data-driven research, and collaborations between biobanks and healthcare institutions are key factors propelling the rapid growth of biobanking services in clinical research applications.

• Regenerative Medicine
• Clinical Research
• Clinical Diagnostics

Biobanking Service End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, the dominating End User is Hospitals. Hospitals have captured the largest market share in the Biobanking Service Market due to their role as primary centers for patient care and medical research. They operate biobanks to store and manage biological samples collected during diagnostics and treatments. Hospitals' biobanks facilitate clinical research, personalized medicine initiatives, and therapeutic developments by providing access to well-characterized patient samples and associated clinical data. Their direct access to diverse patient populations and established healthcare infrastructure further solidifies hospitals as dominant end-users in the biobanking service market.

Diagnostic laboratories are experiencing the highest compound annual growth rate (CAGR) in the Biobanking Service Market due to their increasing role in personalized medicine and molecular diagnostics. These laboratories utilize biobanks to store and analyze biological samples for genetic testing, biomarker discovery, and disease monitoring. The rising demand for precise diagnostic tools and therapies tailored to individual patient profiles drives the expansion of biobanking services within diagnostic laboratories. Additionally, advancements in genomic technologies and regulatory support for diagnostic innovations further propel this growth.

• Hospitals
• Diagnostic Laboratories
• Private Clinics
• Government & Private Research Organizations

Author's Detail

Kalyani Raje

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

An optimistic Senior Research Analyst with years of experience in competitive assessment and business consulting. A seasoned professional and subject-matter expert (SME) in the Automobile & Transportation vertical.

Author's Conclusion